Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
RoboPharma Acquired by Capsa Healthcare to Broaden Reach Into New Pharmacy Automation Markets
2020-08-26 08:12
Adlai Nortye Announces First Patient Dosed in Phase 1b Clinical Trial of AN0025 (EP4 Antagonist) in Combination with Merck's KEYTRUDA® (pembrolizumab) for Advanced Solid Tumors
2020-08-24 13:13
111, Inc. Announces Second Quarter 2020 Unaudited Financial Results
2020-08-20 16:35
China Biologic Reports Financial Results for the Second Quarter of 2020
2020-08-18 04:30
I-Mab Announces First Patient Dosed in Phase 1b Study of Plonmarlimab in Rheumatoid Arthritis in China
2020-08-17 20:00
CARsgen Announces the Publication of a Novel CAR-T Technology that Improves the Efficacy of CAR-T cells Against Solid Tumors without Requiring Preconditioned Lymphodepletion
2020-08-17 18:00
Bushu Pharmaceuticals Announces Major Expansion Program
2020-08-14 14:00
China Biologic Products to Report Second Quarter 2020 Financial Results
2020-08-10 20:00
CMAB Appoints Ms. Maggie Chen as Chief Financial Officer
2020-08-07 08:00
ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies
2020-08-06 23:49
I-Mab to Report Financial Results for the Six Months Ended June 30, 2020 and Provide Corporate Update on August 31, 2020
2020-08-06 20:30
Samsung Biologics launches S-CHOice cell line expression technology
2020-08-05 09:09
China NMPA Accepts IND Application for Eftansomatropin Pivotal Trial in Pediatric Patients with Growth Hormone Deficiency
2020-08-04 20:17
New data independently confirms and extends laboratory findings and expands safety profile of ATH434
2020-08-04 09:33
111 to Announce Second Quarter 2020 Unaudited Financial Results on August 20, 2020
2020-07-31 18:00
Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report
2020-07-31 06:49
New Findings from AAIC Indicated Brain-Gut Axis to be the New Breakthrough in the Research Field of Alzheimer's Disease
2020-07-29 15:28
Viva Biotech and Schrödinger Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets
2020-07-29 07:00
I-Mab Drives Commercialization Strategy with Appointment of Ivan Yifei Zhu as Chief Commercial Officer
2020-07-28 20:22
Foresee Pharmaceuticals Announces Submission of NDA for FDA Approval of LMIS 50 mg
2020-07-28 12:34
1
122
123
124
125
126
170